We present evidence of closely coordinated expression and activation of c-Src and FOXM1 in human breast cancer and demonstrate that targeting c-Src/FOXM1 activity, including through small molecules that trigger FOXM1 degradation, arrested cell-cycle progression, induced apoptosis, and impaired tumor progression and metastasis in multiple preclinical models. This evidence concerns the gene FOXM1 and neoplasm.